Search our site 
 
Advanced Search
 
Home | News | Exam dates | Contact us | About us | Testimonials |
 
 

map
You are in Home >> Resources >> Clinical anaesthesia >> Chronic pain

Local anaesthetics

Created: 7/9/2005
Updated: 12/11/2009

 
The systemic local anaesthetics that are commonly used include lidocaine, tocainide and mexiletine (oral analogue of lidocaine). The assumed mechanism of action to effect analgesia is the acute blocking of sodium channels. Phenytoin, carbamazepine and tricyclic antidepressants (TCAs) also act as sodium channel blockers. Following the use of TCAs and anticonvulsants, local anaesthetics tend to be third-line drugs.

Lidocaine has proven effective for non-cancer patients, but not for those with cancer. In cancer patients, tumour involvement of nervi nervorum with "nociceptive neuropathic pain" may represent a different mechanism, with variable response to therapy. Recent studies have suggested that the duration and pattern of spontaneous discharge is dependent on the level and kinetics of Na+ slow channel inactivation. Slow inactivation of voltage-gated ion channels could be major factors in the induction and treatment of neuropathic pain.

Dosing of mexiletine is begun at 150 mg po qds and is slowly escalated up to a maximum of 10 mg/kg/day as tolerated. The only absolute contraindication to the use of mexiletine is pre–existing second- or third-degree atrioventricular block or known allergy to the medication.
ArticleDate:20050907
SiteSection: Article
 
   
    
                                            
  Posting rules

     To view or add comments you must be a registered user and login  




Login Status  

You are not currently logged in.
UK/Ireland Registration
Overseas Registration

  Forgot your password?








 
All rights reserved © 2016. Designed by AnaesthesiaUK.

{Site map} {Site disclaimer} {Privacy Policy} {Terms and conditions}

 Like us on Facebook 

vp